pharmaphorum | News & views on pharma and biotech’s evolving …
pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
FDA approves flurry of drugs ahead of holiday season
4 days ago · The FDA has followed its usual procedure of wrapping up a series of new drug approvals as the year draws to a close, with Novo Nordisk, Pfizer, Vertex, and Hikma among the beneficiaries.
News | Timely industry updates for pharma and biotech leaders
pharmaphorum’s news coverage updates daily with the latest pharma and biotech stories, from funding and M&A to regulatory approvals and policy shifts.
Deep Dive: AI 2024 | pharmaphorum
Dec 11, 2024 · Deep Dive into the transformative impact of AI on healthcare and pharma, featuring insights on key AI trends from the floor of Frontiers Health, the ongoing battle against drift, and the promise ...
pharmaphorum - The Deep Dive Digital Magazine has fresh …
Feb 28, 2024 · Digital Health 2023. 29-11-2023 Deep Dive – Digital Health 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, AXON, Viseven, Research Partnership, PurpleLeaf Strategy, M3, and more
Deep Dive: Patients & Partnerships 2024 | pharmaphorum
3 days ago · Delve into the critical issues surrounding patients, partnerships, and the US election in 2024. Explore the impact on drug development, pricing, and patient access in this in-depth analysis.
Heard on the pipeline: Access to medication - pharmaphorum
Solving the challenge of access to medication has fuelled many a debate among healthcare stakeholders over the years. Yet, while discussions have been plentiful, even fruitful, patients around the world still struggle to access treatments.
Pharma and the ongoing battle against AI drift | pharmaphorum
Dec 18, 2024 · A study published in Nature, noted that it is less common for the input data to be monitored for data drift (systemic changes to input distributions) and found that monitoring performance alone is ...
Patients’ changing opinions of pharma - pharmaphorum
Respondents listed the industry’s achievements in R&D as the area where the most progress has been made in the last five years. It was the landslide winner, cited by 29% of those questioned, during a period which has seen the first gene therapies marketed, as …
Pills and polls: What the 2024 election means for pharma
4 days ago · President Biden’s passage of the Inflation Reduction Act, which, among many other provisions, allowed Medicare to negotiate drug prices for the first time and set a $35-per-month out-of-pocket ...